Cargando…
Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids
Rationale: Changes in anti-SARS-CoV-2 defense immune subsets in patients treated with dexamethasone (DXM) for severe COVID-19 and their relation to disease outcomes are poorly understood. Methods: Blood-lymphocyte subsets of 110 hospitalized COVID-19 patients were prospectively examined. A first sam...
Autores principales: | Pappas, Apostolos Georgios, Chaliasou, Anna-Louiza, Panagopoulos, Andreas, Dede, Konstantina, Daskalopoulou, Stavroula, Moniem, Evie, Polydora, Eftychia, Grigoriou, Eirini, Psarra, Katherina, Tsirogianni, Alexandra, Kalomenidis, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865280/ https://www.ncbi.nlm.nih.gov/pubmed/36680091 http://dx.doi.org/10.3390/v15010051 |
Ejemplares similares
-
Moderate COVID-19: Clinical Trajectories and Predictors of Progression and Outcomes
por: Pappas, Apostolos G., et al.
Publicado: (2022) -
Predictors of high flow oxygen therapy failure in COVID-19-related severe hypoxemic respiratory failure
por: Polydora, Eftychia, et al.
Publicado: (2022) -
Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion
por: Magkouta, Sophia, et al.
Publicado: (2016) -
A novel ratio of CD8(+):B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome
por: Detsika, Maria G., et al.
Publicado: (2021) -
CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy
por: Magkouta, Sophia Fotiou, et al.
Publicado: (2021)